Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2023
Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical EvaluationRaffaele Palmieri, Giovangiacinto Paterno, Flavia Mallegni, et al.
Frontiers in Immunology|May 13, 2017
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical RelevanceSara Caratelli, Tommaso Sconocchia, Roberto Arriga, et al.
Cytometry. Part B, Clinical Cytometry|August 15, 2006
ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutationsAntonella Zucchetto, Riccardo Bomben, Michele Dal Bo, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2005
Apoptosis and immaturity in acute myeloid leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Adriano Venditti, et al.
Haematologica|September 2, 2004
Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemiaAdriano Venditti, Giovanni Del Poeta, Luca Maurillo, et al.
Cancer|November 14, 2007
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Francesco Buccisano, et al.
Mediterranean Journal of Hematology and Infectious Diseases|June 25, 2013
Treatment of acute myeloid leukemia with 20-30% bone marrow blastsLuca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, et al.
Leukemia & Lymphoma|April 12, 2003
Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemiaAdriano Venditti, Luca Maurillo, Francesco Buccisano, et al.
Haematologica|December 14, 2004
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Adriano Venditti, et al.
Pageof 15